Fire Risk Beds Pulled Nationwide

Red banner with the word RECALL in bold white letters — Photo: Shutterstock

Two people died, and sixteen more were seriously hurt before the Food and Drug Administration (FDA) warned the public that Medline electric beds can catch fire.

Quick Take

The FDA issued an early alert on October 29 about fire risks in Medline brand beds and accessories.
Medline, based in Northfield, Illinois, is pulling every electric bed model off the market.
Hand controls, motors, and control boxes can overheat, smoke, spark, melt, or burst into flame.
Bed rails and wired hand controls have also trapped or suffocated some patients.

What The FDA Found In Medline Beds

The FDA says Medline electric beds, hand-control pendants, control boxes, motor boxes, and actuators can overheat under common conditions. Those conditions include overloading the bed, jammed parts, damaged pendants, spilled liquids, using extension cords, and non-Medline accessories. The agency’s alert describes the result in blunt terms: smoking, sparking, melting, burning, and fire.

Medline told customers it knew of at least two deaths and sixteen serious injuries tied to these beds as of October 20. The company sent an Urgent Medical Device Field Safety Notice to affected customers on October 14, laying out plans to remove, discontinue, or correct every Medline brand bed on the market.

Why Medline Is Pulling Every Bed, Not Just One Model

Medline is not issuing a narrow, single-model recall. The company is exiting the electric bed business entirely, pulling both home-care and long-term care adjustable beds from the market nationwide. That is a sweeping move for a major medical supplier, and it signals the company sees this as a widespread design or manufacturing problem rather than an isolated batch defect.

Fire is not the only danger the FDA flagged. Bed rails and wired hand controls carry a separate risk: patients can become entrapped in the equipment or even asphyxiate. For bedridden or elderly patients who cannot free themselves quickly, that combination of fire and entrapment risk is especially dangerous. The FDA is urging caregivers to unplug affected beds from wall power unless an adjustment truly requires electricity.

What Caregivers And Patients Should Do Right Now

Medline customers already received direct notice about removal, replacement, repair, or refund options starting in mid-October. Families using these beds at home, and facilities using them for long-term care, should check model numbers against the FDA’s posted recall list right away. The agency’s device recall database classified this as a Class 1 recall, the most serious category, reserved for situations where continued use could cause serious injury or death.

This episode fits a familiar pattern in medical device safety. Serious problems often surface only after a product has already reached thousands of homes and nursing facilities. Government auditors have repeatedly found that identifying a dangerous device and correcting it are two separate, slow-moving steps, and that manufacturers largely police the pace of their own recalls. Independent reviews of past Class 1 recalls, the FDA’s most urgent category, found that roughly four in ten cases involved unclear or disputed causes, underscoring how hard these investigations can be to pin down quickly.

None of that uncertainty changes what is already confirmed here. Medline reported the deaths and injuries, the FDA issued the alert, and the company is removing its entire line of electric beds from the market. Families with a Medline bed at home should not wait for more headlines. Call Medline, check the model number, and follow the agency’s unplugging guidance until a fix or replacement arrives.

The Food and Drug Administration is warning that electric hospital beds from medical equipment supplier Medline can pose a fire hazard, after two people died and another 16 users were seriously injured. https://t.co/IxlT8JyAQT

— CBS News (@CBSNews) October 30, 2026

Medical device safety depends on manufacturers reporting problems honestly and regulators acting fast once they do. In this case, both pieces moved: Medline flagged the danger, and the FDA pushed the warning out publicly within weeks. That is the system working as intended, even if it came only after real people were hurt.